[Treatment of the lower urinary tract symptoms secondary to benign prostatic hyperplasia by phosphodiesterase type 5 inhibitors. Review article]. - Caremel R; Oger-Roussel S; Behr-Roussel D; Grise P; Giuliano F (Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, 2010)